The Food and Drug Administration said Monday that it was loosening restrictions on the controversial diabetes drug Avandia "to reflect new information regarding the cardiovascular risk."
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment